misting and ZNO products getting ready for another surge, page-7

Once the H1 report is released we will know. The reports haven't exactly been the most clear, which is something management probably need to improve on. Not saying you are incorrect, its just it hasnt been confirmed as it simply hasn't been reported, for now it's just speculation and I would rather wait until the financial reports. Using a cash flow report can be misleading as revenue and costs are not reported on a cash basis (when cash is received/paid) but an accruals basis (when its been incurred or in Zoonos case dispatched).

There are plenty of trials in play particularly in the US. Provided they are successful, I wouldn't say they are on declining revenue just yet. What is animal health actually worth if some, in particular Iowa state trials, were successful? In my views the next half year is critical, can management achieve a lot of what they presented in the AGM?